This inventor holds 105 USPTO granted patents and 41 published patent applications, plus 14 CIPO patents and 27 EPO patents, primarily in Cancer Detection Technologies (CPC class C12Q1-6886). Top assignees: Exact Sciences Corporation, Exact Sciences Development Company, LLC, Mayo Foundation for Medical Education and Research. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Middelton, WI (US) (2018 - 2021)
- Madison, WI (US) (2013 - 2024)
- Middleton, WI (US) (2018 - 2024)
Company Filing History:
64 out of 115 
34 out of 42 
23 out of 1,823 
Years Active: 2013-2026
Areas of Expertise:
Title: Innovator Spotlight: Graham P. Lidgard - Pioneering Detection of Colorectal Neoplasms
Introduction: Graham P. Lidgard, a prolific inventor based in Madison, WI, has made significant contributions to the field of medical diagnostics with a focus on detecting colorectal neoplasms. With an impressive portfolio of 84 patents, Lidgard's expertise lies in developing innovative technologies for the early detection of premalignant and malignant neoplasms, particularly colorectal cancer.
Latest Patents: Lidgard's most recent patents showcase his groundbreaking work in the realm of detecting colorectal neoplasms. "Detecting Colorectal Neoplasm" introduces novel methods, compositions, and uses for identifying premalignant and malignant neoplasms, while "Digital Sequence Analysis of DNA Methylation" delves into specific methylation patterns indicative of adenoma and carcinoma, aiding in the early diagnosis of these conditions.
Career Highlights: Notably, Lidgard has been affiliated with Exact Sciences Corporation and Exact Sciences Development Company, LLC, prominent companies at the forefront of medical innovation. His expertise and dedication have played a pivotal role in advancing the capabilities of these organizations in the realm of medical diagnostics.
Collaborations: Throughout his career, Lidgard has collaborated with talented individuals such as Hatim T. Allawi and Michael J. Domanico. These partnerships have led to the development of cutting-edge technologies that have revolutionized the early detection and diagnosis of colorectal neoplasms.
Conclusion: Graham P. Lidgard's pioneering work in the field of medical diagnostics, particularly in detecting colorectal neoplasms, underscores his commitment to improving healthcare outcomes through innovation. With a rich portfolio of patents and a history of successful collaborations, Lidgard continues to drive progress in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile